Lakewood-Amedex Biotherapeutics
LABT
#11291
Rank
HK$3.71 M
Marketcap
HK$1.57
Share price
-15.72%
Change (1 day)
N/A
Change (1 year)
Categories

Earnings for Lakewood-Amedex Biotherapeutics (LABT)

Earnings in 2026 (TTM): -HK$56.49 Million

According to Lakewood-Amedex Biotherapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -HK$29.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lakewood-Amedex Biotherapeutics from 2025 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$56.49 Million92.2%
2025 -HK$29.39 Million